Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.
about
Post-translational regulation of endothelial nitric oxide synthase in vascular endotheliumVascular endothelial dysfunction and pharmacological treatmentHemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patientsTranscriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspectiveAssociation between three eNOS polymorphisms and intracranial aneurysms risk: a meta-analysisA novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjectsChaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetesCharacteristics of arterial wall shear stress which cause endothelium-dependent vasodilatation in the anaesthetized dogTumor necrosis factor α decreases nitric oxide synthase type 3 expression primarily via Rho/Rho kinase in the thick ascending limbEndothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient miceeNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries.Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature.Nitric oxide in the pathogenesis of vascular disease.Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population.Careful screening to target interventions to prevent sudden cardiac death.Atherogenesis and the arginine hypothesis.Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteriesA plant-based diet, atherogenesis, and coronary artery disease preventionCyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice.Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosidesImpaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout miceAlternative splicing impairs soluble guanylyl cyclase function in aortic aneurysmOxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase IOverexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation.Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases.Protective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuriesNitric oxide transport in normal human thoracic aorta: effects of hemodynamics and nitric oxide scavengers.Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis.Suppressive Role of PPARγ-Regulated Endothelial Nitric Oxide Synthase in Adipocyte LipolysisNitric oxide insufficiency and atherothrombosis.The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis.Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis.Physiologically relevant measurements of nitric oxide in cardiovascular research using electrochemical microsensors.Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parametersADMA: its role in vascular disease.
P2860
Q21129237-1A2A2A34-2C56-4B95-9463-04667BE807E4Q26774561-9CF259D8-9506-45B7-99FC-E227A25CC874Q26780134-81C856A5-DCEB-4F63-B1E4-6B14FC0A2EE6Q27021826-23555602-F652-4E2F-9DAA-C4B4220B09A0Q28084826-29205E9B-0C96-4C14-A0DC-8885C2018C71Q28221564-0AF8A0AE-866B-469C-878B-9D4B3C3D6C9AQ28251174-E663827D-07BC-46DB-9240-E398426ED594Q28360362-35B1EA02-C091-40FB-861B-6B83B521636DQ28567166-8FBE6777-4154-4FC5-8E3D-4F8D9DA67376Q28584822-E13DCA23-BA6C-4FE7-B646-22119A039F48Q30986269-8E923703-3555-4BA4-A53D-7FE136B0BD6AQ33257976-937C4809-C21A-4605-8194-B67BDE3043A4Q33327002-F38561E2-32B1-4BCE-8AAA-BFD9EA77E690Q33597037-6DEE87A4-D88F-4044-A0BE-0641AE340D4FQ33843539-71992672-B64A-4F83-A42A-DCDE870D7943Q34073360-DDB989BC-64FE-47ED-8B7C-A4348687A000Q34173191-E9931BB4-31BC-4F87-A840-DB18CF930E88Q34207440-CB61A7ED-6F9B-4897-83CF-4EF86719E5C8Q34217803-DAEE587F-9432-4BE3-B246-0F0874311227Q34416131-D836EFAC-16E2-45EB-8A43-EB7BFA5EF077Q34450016-B3E6E5FB-0079-4EF0-AA69-F1FE728CA528Q34501451-30FCBB1A-2816-4621-8E95-378E98B5121EQ34579500-0C2DCB90-392D-4647-9C78-3612614501DDQ34613519-321F7506-0DBD-4653-B85D-6EADE25C6BFEQ34627792-EB6DBEB9-2250-4D3E-A066-24E9C40CC7CBQ34679092-9A120DC1-B692-47FC-91E2-74FAD27D03BCQ34794990-D2FAAAD7-C6D9-4051-937A-C8C2B0A4A9A2Q34816571-C6B095F0-4E75-4F6E-B44F-F711B51E2749Q35090446-92BC3E87-86C4-40D2-832F-B8A7DAE2E5B2Q35109034-20777875-1DEA-4BE1-9A1E-5CF2F45D88A5Q35270619-D74A1C04-5C78-4A25-8FC0-295A19546B77Q35431555-A6C8B651-FCC6-4B1E-A0A0-E284056D5A13Q35552153-ADD2B90D-3230-4834-A5DC-F745A89E1277Q35758566-E31B909C-2A2C-4AA4-A80C-FD4613BF6304Q35874972-9B09E5DB-23DD-4F5B-A47B-EE7F273E2964Q35888589-42D63363-029E-47CB-95AE-8CFFD719BFF9Q36032937-BF11BB59-F974-490B-9F11-36084C541C59Q36308679-65C0DF22-FB84-4AC6-9E23-29BCD14807E0Q36378206-06D80D61-6C16-47B0-9983-A878C9AD84ABQ36380994-7F69BF0E-EA2F-40CF-B3BD-5BA5754B25E7
P2860
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@en
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@nl
type
label
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@en
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@nl
prefLabel
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@en
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@nl
P2093
P1433
P1476
Reduced endothelial nitric oxi ...... tion in human atherosclerosis.
@en
P2093
P304
P356
10.1161/01.CIR.97.25.2494
P407
P577
1998-06-01T00:00:00Z